Eevia Health Plc ('Eevia' or 'The Company') has appointed a Shareholders' Nomination Committee. The following members have been appointed to Eevia's Shareholders' Nomination Committee: Joel Westerström, Partner at Partner Fondkommission AB; Tuomas Lehtimäki, Partner at Smartius Law Firm; Martin Bjørklund, Chairman of the Company's Board of Directors. The nomination is in line with a decision taken by the Annual General Meeting (AGM) held on 22 June 2021.

However, the process of establishing the Nomination Committee has taken longer than originally anticipated. As such, in order to be pragmatic during this first year, the board has decided to simplify the committee for the current period. As such, they have limited the number of members to three.

They anticipate increasing the number of members to four next year. The Nomination Committee is responsible for drafting and presenting proposals covering the remuneration and number of members of the Board of Directors and for presenting candidates as potential Board members to the AGM. The Nomination Committee will forward its proposals for the AGM to the Board of Directors in time for them to be included in the invitation to the meeting sent out to shareholders.